Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Nov 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020
Evolving concepts in the diagnosis and staging of multiple myeloma
Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Evolving concepts in the diagnosis and staging of multiple myeloma ( Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
6 Nov 2020
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
12 Oct 2020
Synchronous invasive ductal carcinoma of the breast and clear cell renal...
Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon
Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behaviour ( Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon )
8 Oct 2020
PROFound trial and other recent updates in prostate cancer
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
PROFound trial and other recent updates in prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Sep 2020
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma
Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma ( Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain )
25 Sep 2020
Exon 20 insertions in NSCLC - ESMO 2020
Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro
Exon 20 insertions in NSCLC - ESMO 2020 ( Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro )
25 Sep 2020
ESMO 2020: Lung cancer latest
Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay...
ESMO 2020: Lung cancer latest ( Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat )
25 Sep 2020
Highlights from ESMO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ESMO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2020
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients...
Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC ( Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA )
23 Sep 2020
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004 ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )
22 Sep 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation